1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Dravet Syndrome Thereapeutics Market Size Growth Rate by Type: 2020 VS 2026 1.2.2 BIS-001 1.2.3 Cannabidiol 1.2.4 CUR-1916 1.2.5 SAGE-217 1.2.6 Others 1.3 Market by Application 1.3.1 Global Dravet Syndrome Thereapeutics Market Share by Application: 2020 VS 2026 1.3.2 Clinic 1.3.3 Hospital 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Dravet Syndrome Thereapeutics Market Perspective (2015-2026) 2.2 Global Dravet Syndrome Thereapeutics Growth Trends by Regions 2.2.1 Dravet Syndrome Thereapeutics Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Dravet Syndrome Thereapeutics Historic Market Share by Regions (2015-2020) 2.2.3 Dravet Syndrome Thereapeutics Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Dravet Syndrome Thereapeutics Players by Market Size 3.1.1 Global Top Dravet Syndrome Thereapeutics Players by Revenue (2015-2020) 3.1.2 Global Dravet Syndrome Thereapeutics Revenue Market Share by Players (2015-2020) 3.2 Global Dravet Syndrome Thereapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Dravet Syndrome Thereapeutics Revenue 3.4 Global Dravet Syndrome Thereapeutics Market Concentration Ratio 3.4.1 Global Dravet Syndrome Thereapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Dravet Syndrome Thereapeutics Revenue in 2019 3.5 Key Players Dravet Syndrome Thereapeutics Area Served 3.6 Key Players Dravet Syndrome Thereapeutics Product Solution and Service 3.7 Date of Enter into Dravet Syndrome Thereapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Dravet Syndrome Thereapeutics Breakdown Data by Type (2015-2026) 4.1 Global Dravet Syndrome Thereapeutics Historic Market Size by Type (2015-2020) 4.2 Global Dravet Syndrome Thereapeutics Forecasted Market Size by Type (2021-2026) 5 Dravet Syndrome Thereapeutics Breakdown Data by Application (2015-2026) 5.1 Global Dravet Syndrome Thereapeutics Historic Market Size by Application (2015-2020) 5.2 Global Dravet Syndrome Thereapeutics Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Dravet Syndrome Thereapeutics Market Size (2015-2026) 6.2 North America Dravet Syndrome Thereapeutics Market Size by Type (2015-2020) 6.3 North America Dravet Syndrome Thereapeutics Market Size by Application (2015-2020) 6.4 North America Dravet Syndrome Thereapeutics Market Size by Country (2015-2020) 6.4.1 United States 6.4.2 Canada 7 Europe 7.1 Europe Dravet Syndrome Thereapeutics Market Size (2015-2026) 7.2 Europe Dravet Syndrome Thereapeutics Market Size by Type (2015-2020) 7.3 Europe Dravet Syndrome Thereapeutics Market Size by Application (2015-2020) 7.4 Europe Dravet Syndrome Thereapeutics Market Size by Country (2015-2020) 7.4.1 Germany 7.4.2 France 7.4.3 U.K. 7.4.4 Italy 7.4.5 Russia 7.4.6 Nordic 7.4.7 Rest of Europe 8 China 8.1 China Dravet Syndrome Thereapeutics Market Size (2015-2026) 8.2 China Dravet Syndrome Thereapeutics Market Size by Type (2015-2020) 8.3 China Dravet Syndrome Thereapeutics Market Size by Application (2015-2020) 8.4 China Dravet Syndrome Thereapeutics Market Size by Region (2015-2020) 8.4.1 China 8.4.2 Japan 8.4.3 South Korea 8.4.4 Southeast Asia 8.4.5 India 8.4.6 Australia 8.4.7 Rest of Asia-Pacific 9 Japan 9.1 Japan Dravet Syndrome Thereapeutics Market Size (2015-2026) 9.2 Japan Dravet Syndrome Thereapeutics Market Size by Type (2015-2020) 9.3 Japan Dravet Syndrome Thereapeutics Market Size by Application (2015-2020) 9.4 Japan Dravet Syndrome Thereapeutics Market Size by Country (2015-2020) 9.4.1 Mexico 9.4.2 Brazil 10 Southeast Asia 10.1 Southeast Asia Dravet Syndrome Thereapeutics Market Size (2015-2026) 10.2 Southeast Asia Dravet Syndrome Thereapeutics Market Size by Type (2015-2020) 10.3 Southeast Asia Dravet Syndrome Thereapeutics Market Size by Application (2015-2020) 10.4 Southeast Asia Dravet Syndrome Thereapeutics Market Size by Country (2015-2020) 10.4.1 Turkey 10.4.2 Saudi Arabia 10.4.3 UAE 10.4.4 Rest of Middle East & Africa 11 Key Players Profiles 11.1 Biscayne Pharmaceuticals, Inc. 11.1.1 Biscayne Pharmaceuticals, Inc. Company Details 11.1.2 Biscayne Pharmaceuticals, Inc. Business Overview 11.1.3 Biscayne Pharmaceuticals, Inc. Dravet Syndrome Thereapeutics Introduction 11.1.4 Biscayne Pharmaceuticals, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2015-2020)) 11.1.5 Biscayne Pharmaceuticals, Inc. Recent Development 11.2 GW Pharmaceuticals Plc 11.2.1 GW Pharmaceuticals Plc Company Details 11.2.2 GW Pharmaceuticals Plc Business Overview 11.2.3 GW Pharmaceuticals Plc Dravet Syndrome Thereapeutics Introduction 11.2.4 GW Pharmaceuticals Plc Revenue in Dravet Syndrome Thereapeutics Business (2015-2020) 11.2.5 GW Pharmaceuticals Plc Recent Development 11.3 INSYS Therapeutics, Inc. 11.3.1 INSYS Therapeutics, Inc. Company Details 11.3.2 INSYS Therapeutics, Inc. Business Overview 11.3.3 INSYS Therapeutics, Inc. Dravet Syndrome Thereapeutics Introduction 11.3.4 INSYS Therapeutics, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2015-2020) 11.3.5 INSYS Therapeutics, Inc. Recent Development 11.4 OPKO Health, Inc. 11.4.1 OPKO Health, Inc. Company Details 11.4.2 OPKO Health, Inc. Business Overview 11.4.3 OPKO Health, Inc. Dravet Syndrome Thereapeutics Introduction 11.4.4 OPKO Health, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2015-2020) 11.4.5 OPKO Health, Inc. Recent Development 11.5 PTC Therapeutics, Inc. 11.5.1 PTC Therapeutics, Inc. Company Details 11.5.2 PTC Therapeutics, Inc. Business Overview 11.5.3 PTC Therapeutics, Inc. Dravet Syndrome Thereapeutics Introduction 11.5.4 PTC Therapeutics, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2015-2020) 11.5.5 PTC Therapeutics, Inc. Recent Development 11.6 Sage Therapeutics, Inc. 11.6.1 Sage Therapeutics, Inc. Company Details 11.6.2 Sage Therapeutics, Inc. Business Overview 11.6.3 Sage Therapeutics, Inc. Dravet Syndrome Thereapeutics Introduction 11.6.4 Sage Therapeutics, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2015-2020) 11.6.5 Sage Therapeutics, Inc. Recent Development 11.7 Xenon Pharmaceuticals Inc. 11.7.1 Xenon Pharmaceuticals Inc. Company Details 11.7.2 Xenon Pharmaceuticals Inc. Business Overview 11.7.3 Xenon Pharmaceuticals Inc. Dravet Syndrome Thereapeutics Introduction 11.7.4 Xenon Pharmaceuticals Inc. Revenue in Dravet Syndrome Thereapeutics Business (2015-2020) 11.7.5 Xenon Pharmaceuticals Inc. Recent Development 11.8 Zogenix, Inc. 11.8.1 Zogenix, Inc. Company Details 11.8.2 Zogenix, Inc. Business Overview 11.8.3 Zogenix, Inc. Dravet Syndrome Thereapeutics Introduction 11.8.4 Zogenix, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2015-2020) 11.8.5 Zogenix, Inc. Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Dravet Syndrome Thereapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 3. Key Players of BIS-001 Table 4. Key Players of Cannabidiol Table 5. Key Players of CUR-1916 Table 6. Key Players of SAGE-217 Table 7. Key Players of Others Table 8. Global Dravet Syndrome Thereapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 9. Global Dravet Syndrome Thereapeutics Market Size by Regions (US$ Million): 2020 VS 2026 Table 10. Global Dravet Syndrome Thereapeutics Market Size by Regions (2015-2020) (US$ Million) Table 11. Global Dravet Syndrome Thereapeutics Market Share by Regions (2015-2020) Table 12. Global Dravet Syndrome Thereapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 13. Global Dravet Syndrome Thereapeutics Market Share by Regions (2021-2026) Table 14. Dravet Syndrome Thereapeutics Market Market Trends Table 15. Dravet Syndrome Thereapeutics Market Drivers Table 16. Dravet Syndrome Thereapeutics Market Challenges Table 17. Dravet Syndrome Thereapeutics Market Restraints Table 18. Global Dravet Syndrome Thereapeutics Revenue by Players (2015-2020) (US$ Million) Table 19. Global Dravet Syndrome Thereapeutics Market Share by Players (2015-2020) Table 20. Global Top Dravet Syndrome Thereapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dravet Syndrome Thereapeutics as of 2019) Table 21. Global Dravet Syndrome Thereapeutics by Players Market Concentration Ratio (CR5 and HHI) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Dravet Syndrome Thereapeutics Product Solution and Service Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Dravet Syndrome Thereapeutics Market Size by Type (2015-2020) (US$ Million) Table 26. Global Dravet Syndrome Thereapeutics Market Size Share by Type (2015-2020) Table 27. Global Dravet Syndrome Thereapeutics Revenue Market Share by Type (2021-2026) Table 28. Global Dravet Syndrome Thereapeutics Market Size Share by Application (2015-2020) Table 29. Global Dravet Syndrome Thereapeutics Market Size by Application (2015-2020) (US$ Million) Table 30. Global Dravet Syndrome Thereapeutics Market Size Share by Application (2021-2026) Table 31. North America Dravet Syndrome Thereapeutics Market Size by Type (2015-2020) (US$ Million) Table 32. North America Dravet Syndrome Thereapeutics Market Share by Type (2015-2020) Table 33. North America Dravet Syndrome Thereapeutics Market Size by Application (2015-2020) (US$ Million) Table 34. North America Dravet Syndrome Thereapeutics Market Share by Application (2015-2020) Table 35. North America Dravet Syndrome Thereapeutics Market Size by Country (US$ Million) (2015-2020) Table 36. North America Dravet Syndrome Thereapeutics Market Share by Country (2015-2020) Table 37. Europe Dravet Syndrome Thereapeutics Market Size by Type (2015-2020) (US$ Million) Table 38. Europe Dravet Syndrome Thereapeutics Market Share by Type (2015-2020) Table 39. Europe Dravet Syndrome Thereapeutics Market Size by Application (2015-2020) (US$ Million) Table 40. Europe Dravet Syndrome Thereapeutics Market Share by Application (2015-2020) Table 41. Europe Dravet Syndrome Thereapeutics Market Size by Country (US$ Million) (2015-2020) Table 42. Europe Dravet Syndrome Thereapeutics Market Share by Country (2015-2020) Table 43. China Dravet Syndrome Thereapeutics Market Size by Type (2015-2020) (US$ Million) Table 44. China Dravet Syndrome Thereapeutics Market Share by Type (2015-2020) Table 45. China Dravet Syndrome Thereapeutics Market Size by Application (2015-2020) (US$ Million) Table 46. China Dravet Syndrome Thereapeutics Market Share by Application (2015-2020) Table 47. China Dravet Syndrome Thereapeutics Market Size by Region (US$ Million) (2015-2020) Table 48. China Dravet Syndrome Thereapeutics Market Share by Region (2015-2020) Table 49. Japan Dravet Syndrome Thereapeutics Market Size by Type (2015-2020) (US$ Million) Table 50. Japan Dravet Syndrome Thereapeutics Market Share by Type (2015-2020) Table 51. Japan Dravet Syndrome Thereapeutics Market Size by Application (2015-2020) (US$ Million) Table 52. Japan Dravet Syndrome Thereapeutics Market Share by Application (2015-2020) Table 53. Japan Dravet Syndrome Thereapeutics Market Size by Country (US$ Million) (2015-2020) Table 54. Japan Dravet Syndrome Thereapeutics Market Share by Country (2015-2020) Table 55. Southeast Asia Dravet Syndrome Thereapeutics Market Size by Type (2015-2020) (US$ Million) Table 56. Southeast Asia Dravet Syndrome Thereapeutics Market Share by Type (2015-2020) Table 57. Southeast Asia Dravet Syndrome Thereapeutics Market Size by Application (2015-2020) (US$ Million) Table 58. Southeast Asia Dravet Syndrome Thereapeutics Market Share by Application (2015-2020) Table 59. Southeast Asia Dravet Syndrome Thereapeutics Market Size by Country (US$ Million) (2015-2020) Table 60. Southeast Asia Dravet Syndrome Thereapeutics Market Share by Country (2015-2020) Table 61. Biscayne Pharmaceuticals, Inc. Company Details Table 62. Biscayne Pharmaceuticals, Inc. Business Overview Table 63. Biscayne Pharmaceuticals, Inc. Product Table 64. Biscayne Pharmaceuticals, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2015-2020) (US$ Million) Table 65. Biscayne Pharmaceuticals, Inc. Recent Development Table 66. GW Pharmaceuticals Plc Company Details Table 67. GW Pharmaceuticals Plc Business Overview Table 68. GW Pharmaceuticals Plc Product Table 69. GW Pharmaceuticals Plc Revenue in Dravet Syndrome Thereapeutics Business (2015-2020) (US$ Million) Table 70. GW Pharmaceuticals Plc Recent Development Table 71. INSYS Therapeutics, Inc. Company Details Table 72. INSYS Therapeutics, Inc. Business Overview Table 73. INSYS Therapeutics, Inc. Product Table 74. INSYS Therapeutics, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2015-2020) (US$ Million) Table 75. INSYS Therapeutics, Inc. Recent Development Table 76. OPKO Health, Inc. Company Details Table 77. OPKO Health, Inc. Business Overview Table 78. OPKO Health, Inc. Product Table 79. OPKO Health, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2015-2020) (US$ Million) Table 80. OPKO Health, Inc. Recent Development Table 81. PTC Therapeutics, Inc. Company Details Table 82. PTC Therapeutics, Inc. Business Overview Table 83. PTC Therapeutics, Inc. Product Table 84. PTC Therapeutics, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2015-2020) (US$ Million) Table 85. PTC Therapeutics, Inc. Recent Development Table 86. Sage Therapeutics, Inc. Company Details Table 87. Sage Therapeutics, Inc. Business Overview Table 88. Sage Therapeutics, Inc. Product Table 89. Sage Therapeutics, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2015-2020) (US$ Million) Table 90. Sage Therapeutics, Inc. Recent Development Table 91. Xenon Pharmaceuticals Inc. Company Details Table 92. Xenon Pharmaceuticals Inc. Business Overview Table 93. Xenon Pharmaceuticals Inc. Product Table 94. Xenon Pharmaceuticals Inc. Revenue in Dravet Syndrome Thereapeutics Business (2015-2020) (US$ Million) Table 95. Xenon Pharmaceuticals Inc. Recent Development Table 96. Zogenix, Inc. Business Overview Table 97. Zogenix, Inc. Product Table 98. Zogenix, Inc. Company Details Table 99. Zogenix, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2015-2020) (US$ Million) Table 100. Zogenix, Inc. Recent Development Table 101. Research Programs/Design for This Report Table 102. Key Data Information from Secondary Sources Table 103. Key Data Information from Primary Sources List of Figures Figure 1. Global Dravet Syndrome Thereapeutics Market Share by Type: 2020 VS 2026 Figure 2. BIS-001 Features Figure 3. Cannabidiol Features Figure 4. CUR-1916 Features Figure 5. SAGE-217 Features Figure 6. Others Features Figure 7. Global Dravet Syndrome Thereapeutics Market Share by Application: 2020 VS 2026 Figure 8. Clinic Case Studies Figure 9. Hospital Case Studies Figure 10. Others Case Studies Figure 11. Dravet Syndrome Thereapeutics Report Years Considered Figure 12. Global Dravet Syndrome Thereapeutics Market Size (US$ Million), YoY Growth 2015-2026 Figure 13. Global Dravet Syndrome Thereapeutics Market Share by Regions: 2020 VS 2026 Figure 14. Global Dravet Syndrome Thereapeutics Market Share by Regions (2021-2026) Figure 15. Global Dravet Syndrome Thereapeutics Market Share by Players in 2019 Figure 16. Global Top Dravet Syndrome Thereapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dravet Syndrome Thereapeutics as of 2019 Figure 17. The Top 10 and 5 Players Market Share by Dravet Syndrome Thereapeutics Revenue in 2019 Figure 18. North America Dravet Syndrome Thereapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 19. United States Dravet Syndrome Thereapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 20. Canada Dravet Syndrome Thereapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 21. Europe Dravet Syndrome Thereapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 22. Germany Dravet Syndrome Thereapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 23. France Dravet Syndrome Thereapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 24. U.K. Dravet Syndrome Thereapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 25. Italy Dravet Syndrome Thereapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 26. Russia Dravet Syndrome Thereapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 27. Nordic Dravet Syndrome Thereapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 28. Rest of Europe Dravet Syndrome Thereapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 29. Asia-Pacific Dravet Syndrome Thereapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 30. China Dravet Syndrome Thereapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 31. Japan Dravet Syndrome Thereapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 32. South Korea Dravet Syndrome Thereapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 33. Southeast Asia Dravet Syndrome Thereapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 34. India Dravet Syndrome Thereapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 35. Australia Dravet Syndrome Thereapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 36. Rest of Asia-Pacific Dravet Syndrome Thereapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 37. Latin America Dravet Syndrome Thereapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 38. Mexico Dravet Syndrome Thereapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 39. Brazil Dravet Syndrome Thereapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 40. Middle East & Africa Dravet Syndrome Thereapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 41. Turkey Dravet Syndrome Thereapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 42. Saudi Arabia Dravet Syndrome Thereapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 43. UAE Dravet Syndrome Thereapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 44. Rest of Middle East & Africa Dravet Syndrome Thereapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 45. Biscayne Pharmaceuticals, Inc. Revenue Growth Rate in Dravet Syndrome Thereapeutics Business (2015-2020) Figure 46. GW Pharmaceuticals Plc Revenue Growth Rate in Dravet Syndrome Thereapeutics Business (2015-2020) Figure 47. INSYS Therapeutics, Inc. Revenue Growth Rate in Dravet Syndrome Thereapeutics Business (2015-2020) Figure 48. OPKO Health, Inc. Revenue Growth Rate in Dravet Syndrome Thereapeutics Business (2015-2020) Figure 49. PTC Therapeutics, Inc. Revenue Growth Rate in Dravet Syndrome Thereapeutics Business (2015-2020) Figure 50. Sage Therapeutics, Inc. Revenue Growth Rate in Dravet Syndrome Thereapeutics Business (2015-2020) Figure 51. Xenon Pharmaceuticals Inc. Revenue Growth Rate in Dravet Syndrome Thereapeutics Business (2015-2020) Figure 52. Zogenix, Inc. Revenue Growth Rate in Dravet Syndrome Thereapeutics Business (2015-2020) Figure 53. Bottom-up and Top-down Approaches for This Report Figure 54. Data Triangulation Figure 55. Key Executives Interviewed

Biscayne Pharmaceuticals, Inc. GW Pharmaceuticals Plc INSYS Therapeutics, Inc. OPKO Health, Inc. PTC Therapeutics, Inc. Sage Therapeutics, Inc. Xenon Pharmaceuticals Inc. Zogenix, Inc.